Pemigatinib For Previously Treated Central Nervous System Tumors With Activating FGFR Mutations or Translocations: Results From FIGHT-207 (S17.004)
Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available
10.1212/wnl.0000000000203833